REVERSED
1600 Biotechnology and Organic Chemistry
07/21/2011 1655 Ex Parte Yang 10/505,015 ADAMS 103(a) WANG & HO EXAMINER LEITH, PATRICIA A
2600 Communications
07/22/2011 2624 Ex Parte Fushiki et al 11/041,033 KOHUT 102(b)/103(a) WESTMAN CHAMPLIN (MICROSOFT CORPORATION) EXAMINER WANG, CLAIRE X
REEXAMINATION EXAMINER AFFIRMED-IN-PART
3900 Central Reexamination Unit (CRU)
07/22/2011 3765 Ex parte CHRISTOPER SEAN VAN WINKLE and DAVID COX Appellants 90/009,210 7,076,806 SONG 102(b)/103(a) WOMBLE CARLYLE SANDRIDGE & RICE, PLLC Third Party Requester: VENABLE LLP EXAMINER FETSUGA, ROBERT M original EXAMINER PATEL, TAJASH D
AFFIRMED
1700 Chemical & Materials Engineering
07/22/2011 1727 Ex Parte Vyas et al 11/089,525 NAGUMO 102(b)/obviousness-type double patenting MILLER IP GROUP, PLC GENERAL MOTORS CORPORATION EXAMINER SCULLY, STEVEN M
07/21/2011 1747 Ex Parte Yokota et al 10/277,646 GUEST 103(a) BRIDGESTONE AMERICAS HOLDINGS, INC. EXAMINER FISCHER, JUSTIN R
The word “substantially” has been construed many times by our reviewing court. While the term “substantially” certainly broadens the term it modifies to some degree, it “cannot be allowed to negate the meaning of the word it modifies.” In re Hauserman, Inc., 892 F.2d 1049 (Fed. Cir. 1989) (quoting Arvin Industries, Inc. v. Berns Air King Corp., 525 F.2d 182, 185 (7th Cir. 1975)).
07/22/2011 1731 Ex Parte Bailey et al 10/820,972 OWENS 103(a) K&L GATES LLP EXAMINER ABU ALI, SHUANGYI
That argument is not persuasive because, first, evidence must not merely show an unexpected property but, rather, must show an unexpected difference in a property between the claimed invention and the prior art. See In re Freeman, 474 F.2d 1318, 1324 (CCPA 1973). Second, the Appellants have not provided a side-by-side comparison of the claimed invention with the closest prior art which is commensurate in scope with the claims, and explained why the results would have been unexpected by one of ordinary skill in the art. See In re Baxter Travenol Labs., 952 F.2d 388, 392 (Fed. Cir. 1991); In re De Blauwe, 736 F.2d 699, 705 (Fed. Cir. 1984); In re Grasselli, 713 F.2d 731, 743 (Fed. Cir. 1983); In re Clemens, 622 F.2d 1029, 1035 (CCPA 1980); In re Freeman, 474 F.2d at 1324; In re Klosak, 455 F.2d 1077, 1080 (CCPA 1972).
Baxter Travenol Labs., In re, 952 F.2d 388, 21 USPQ2d 1281 (Fed. Cir. 1991) . . .2131.01, 2145
De Blauwe, In re, 736 F.2d 699, 222 USPQ 191 (Fed. Cir. 1984) . . . 716.01(c), 2145
Grasselli, In re, 713 F.2d 731, 218 USPQ 769 (Fed. Cir. 1983) . . . . . . . 716.02(d), 2112, 2145
Clemens, In re, 622 F.2d 1029, 206 USPQ 289 (CCPA 1980) . . . . . 716.02(d), 2145
07/21/2011 1796 Ex Parte Dreier et al 11/032,434 ROBERTSON 103(a) BAYER MATERIAL SCIENCE LLC EXAMINER COONEY, JOHN M
A showing of unexpected results may be sufficient to overcome a prima facie case of obviousness. In re Dillon, 919 F.2d 688, 692-93 (Fed. Cir. 1990) (internal citations omitted). Such a showing must be based on evidence, not argument or speculation. In re Mayne, 104 F.3d 1339, 1343-44 (Fed. Cir. 1997); In re Schulze, 346 F.2d 600, 602 (CCPA 1965). The evidence must also be reasonably commensurate in scope with the claimed invention. In re Greenfield, 571 F.2d 1185, 1189 (CCPA 1978). Further, the Federal Circuit has held that when the difference between a claimed invention and the prior art is a claimed range; the applicant must show that the range is critical through unexpected results. In re Woodruff, 919 F.2d 1575, 1578 (Fed. Cir. 1990) (internal citations omitted).
Dillon, In re, 919 F.2d 688, 16 USPQ2d 1897 (Fed. Cir. 1990) . . . . . . . . . . . 2141, 2144, 2144.09, 2145
Mayne, In re, 104 F.3d 1339, 41 USPQ2d 1451 (Fed. Cir. 1977) . . . . . . . . . . . .2144.09, 2145
Schulze, In re, 346 F.2d 600, 145 USPQ 716 (CCPA 1965) . . . .716.01(c), 2145, 2164.06(c)
Greenfield, In re, 571 F.2d 1185, 197 USPQ 227 (CCPA 1978) . . . . . . . . . . . . . .2145
Woodruff, In re, 919 F.2d 1575, 16 USPQ2d 1934 (Fed. Cir. 1990) . . . . . . . 2144.05
2100 Computer Architecture and Software
07/21/2011 2162 Ex Parte Marsh et al 11/058,972 THOMAS 103(a) Baker Botts L.L.P EXAMINER BULLOCK, JOSHUA
07/22/2011 2164 Ex Parte Avinash et al 11/016,081 MORGAN 103(a) Patrick S. Yoder FLETCHER YODER EXAMINER ADAMS, CHARLES D
07/21/2011 2181 Ex Parte Azadet et al 10/880,331 GONSALVES 102(e)/103(a) RYAN, MASON & LEWIS, LLP EXAMINER UNELUS, ERNEST
2400 Networking, Multiplexing, Cable, and Security
07/21/2011 2456 Ex Parte Karaoguz et al 10/672,601 DANG 103(a) MCANDREWS HELD & MALLOY, LTD EXAMINER BATES, KEVIN T
2600 Communications
07/21/2011 2617 Ex Parte Filipovic et al 10/412,928 RUGGIERO 103(a) QUALCOMM INCORPORATED EXAMINER D AGOSTA, STEPHEN M
SEARCH
PTAB.US: Decisions of PTAB Patent Trial and Appeal Board
Li & Cai
Showing posts with label arvin. Show all posts
Showing posts with label arvin. Show all posts
Friday, July 22, 2011
Subscribe to:
Posts
(
Atom
)